Eliquis Tablets (Apixaban 2.5mg & 5mg) | Direct Oral Anticoagulant for Stroke Prevention & Blood Clot Management

Product Description

Product Overview and Introduction

Protect against stroke, systemic embolism, and dangerous blood clot formation with Eliquis Tablets (Apixaban). As a premier, gold-standard direct oral anticoagulant (DOAC) trusted worldwide by cardiologists and vascular specialists, Eliquis is prescribed to reduce the risk of stroke in patients with nonvalvular atrial fibrillation, as well as to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE). Engineered to target specific clotting cascades with high precision, it offers modern, reliable cardiovascular protection without the rigid dietary restrictions associated with older therapies.

At the core of Eliquis is apixaban, a potent, reversible, and selective active site inhibitor of Factor Xa. Factor Xa is a critical enzyme at the convergence of the intrinsic and extrinsic coagulation pathways that converts prothrombin into thrombin. By selectively blocking Factor Xa, apixaban prevents the generation of thrombin and the subsequent development of fibrin clot formation, safely interrupting the coagulation process before clots can form or grow.

Key Engineering and Clinical Highlights

Manufactured under strict pharmaceutical controls to ensure predictable pharmacokinetics, consistent systemic bioavailability, and reliable potency, Eliquis delivers rigorous clinical performance:

• Targeted Factor Xa Inhibition: Selectively neutralizes Factor Xa to interrupt the clotting cascade at its most critical juncture with high specificity.

• No Routine Blood Monitoring Required: Unlike traditional warfarin therapy, apixaban provides a predictable anticoagulant response, eliminating the need for frequent International Normalized Ratio (INR) lab checks.

• Proven Stroke and Clot Protection: Backed by landmark clinical trials demonstrating superior safety and efficacy in reducing stroke risk and venous thromboembolism recurrences.

• Standardized Dosage Strengths: Available in 2.5mg and 5mg oral tablet formulations to accommodate initial treatment phases, chronic maintenance, and specialized patient renal protocols.

The Definitive Gold Standard in Modern Anticoagulation Care

When clinical cardiology and vascular protocols require a cutting-edge, highly reliable blood thinner that balances exceptional clot prevention with a favorable safety profile, Eliquis stands out as the ultimate frontline therapeutic standard.

Key Features and Benefits

• Reliable Vascular Defense: Significantly lowers the incidence of disabling strokes in atrial fibrillation and stops deep-seated clots from traveling to the lungs.

• Dietary Freedom: Functions independently of vitamin K intake, allowing patients to maintain normal, consistent dietary habits without sudden restrictions.

Specifications

• Product Type: Prescription Direct Oral Anticoagulant (DOAC) / Factor Xa Inhibitor

• Active Ingredient: Apixaban (Available in 2.5mg and 5mg film-coated oral tablets)

• Indication: Prevention of Stroke and Systemic Embolism in Nonvalvular Atrial Fibrillation; Treatment and Prophylaxis of DVT and PE

• Packaging: Pharmaceutical Blister Packs or Dispensing Bottles (Standard blister strips or 60-tablet monthly supplies)

• Administration Route: Oral Tablet (Taken twice daily with or without food)

• Condition: Brand New Pharmaceutical Grade (Requires Strict Prescription and Medical Supervision)

Additional Information